Uridine di- or tri-phosphate derivatives and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9221868
APP PUB NO 20130324495A1
SERIAL NO

13990491

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure provides particular uridine di- and tri-phosphate compounds of Formula I, and pharmaceutical compositions thereof. The definitions of variables such as R, Y, B, m, Z1, Z2, and Z3 are as provided in the disclosure. These compounds are useful for treatment of diseases, disorders and conditions modulated by P2Y6 receptors, and particularly for lowering intraocular pressure and thereby treating ocular hypertension and/or glaucoma.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAR-ILAN UNIVERSITYRAMAT GAN
UNIVERSIDAD COMPLUTENSE DE MADRIDAVENIDA DE SENECA 2 OTRI FAC DE MEDICINA - CIUDAD UNIVERSITARIA MADRID 28040

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Elyahu, Shay Ramat-Efal, IL 1 11
Fischer, Bilha Shoham, IL 12 61
Ginsburg-Shmuel, Tamar Ra'anana, IL 1 11
Pintor, Jesus Jeronimo Madrid, ES 1 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 29, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00